Lexology May 23, 2024
Morgan, Lewis & Bockius LLP

On May 21, 2024, The Drug Enforcement Administration (DEA) issued a notice of proposed rulemaking in the Federal Register (FR) to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). This announcement comes nearly a year after the US Department of Health and Human Services (HHS) August 29, 2023 letter to the DEA recommending that marijuana be rescheduled. It also follows an April 11, 2024 opinion letter from the DOJ Office of Legal Counsel that the United States’ international treaty obligations do not prevent rescheduling marijuana. The proposed rule represents the most significant policy shift for marijuana since the passage of the CSA in 1970, which categorized marijuana as a Schedule I controlled substance.

The...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, HHS, Patient / Consumer, Provider
Trump administration policies could create headwinds across healthcare: Fitch
Exclusive: Mary Meeker's serious warning for "USA Inc."
What HHS' public comment rollback means for hospitals: 3 federal health updates
More states eye removing requirements for foreign-trained physicians
Short-circuiting US innovation

Share This Article